Evidence map›Paper›PMID 34076784›Full record

ArticleInternational ophthalmology2021

Secondary DMEK following failed primary DMEK.

Konstantinos Droutsas, Palaiologos Alexopoulos, Ioannis Giachos, Eleftherios Giallouros, Walter Sekundo, Apostolos Lazaridis

Abstract read
PubMed Publisher
In one paragraph

Article in International ophthalmology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Konstantinos DroutsasFirst Department of Ophthalmology, School of Medicine, National and Kapodistrian University of Athens, 11527, Athens, Greece.
Palaiologos AlexopoulosFirst Department of Ophthalmology, School of Medicine, National and Kapodistrian University of Athens, 11527, Athens, Greece.
Ioannis GiachosFirst Department of Ophthalmology, School of Medicine, National and Kapodistrian University of Athens, 11527, Athens, Greece. giaxosgiannis@hotmail.com.ORCID http://orcid.org/0000-0002-6913-4539
Eleftherios GiallourosDepartment of Ophthalmology, Philipps University, 35043, Marburg, Germany.
Walter SekundoDepartment of Ophthalmology, Philipps University, 35043, Marburg, Germany.
Apostolos LazaridisDepartment of Ophthalmology, Philipps University, 35043, Marburg, Germany.
Philipps University of Marburg · DENational and Kapodistrian University of Athens · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo report the outcomes of secondary Descemet Membrane Endothelial Keratoplasty (DMEK) performed for failed primary DMEK.

methodsThe medical records of all patients undergoing secondary DMEK due to failure of primary DMEK were reviewed. Reasons for failure were sought and best-corrected visual acuity (BCVA), endothelial cell density (ECD) and complications of secondary DMEK were evaluated.

resultsA total of 10 cases undergoing secondary DMEK following failed primary DMEK were identified. Presumed reasons for failure included donor ECD ≤ 2300 cells/mm

conclusionsApart from low donor ECD, surgical challenges, i.e., difficulty with graft preparation, inverse graft positioning, and retroiridal air dislocation, were main reasons for failure of primary DMEK. Secondary DMEK showed a good safety profile and reasonable visual outcomes.

Indexed as

Descemet Stripping Endothelial KeratoplastyFuchs' Endothelial DystrophyGlaucoma, Open-AngleCell CountDescemet MembraneEndothelium, CornealGraft RejectionHumansMaleRetrospective StudiesVisual AcuityDMEKDSAEKEndothelial cell densityGraft survivalPenetrating keratoplasty

Identifiers

PMID34076784
OpenAlexW3164522534

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.